This observation aligns with findings by Dinarello et al., who reported elevated IL-32 expression levels in various inflammatory diseases, including CD, and found that IL-32 levels correlated with disease severity 86
1.9%), and weight increased (3.7% vs
Genetic factors influence how your immune and inflammatory pathways respond to GLP-1 compoundssomething PlexusDx explores through the Precision Peptide Genetic Test, which maps 14 metabolic and immune-related pathways
[DOI] [PubMed] [Google Scholar] Challa T.D., Beaton N., Arnold M., Rudofsky G., Langhans W., Wolfrum C
For enhanced results, consider Zepbound (tirzepatide), a dual-action GLP-1 medication
You can reduce your risk for semaglutide side effects and manage them if you have them